Genethon Lecture Series: 2017, September 12th

  • Le mardi 12 septembre 2017 :

“Single domain antibodies as potential therapeutic tools in bleeding disorders”

Dr. Peter Lenting, Director of Research , Inserm U1176 , Haemostasis-Inflammation-Thrombosis, CHU Bicêtre, Kremlin Bicêtre, Paris, France.